Showing 29 of 29 results

PATH, Agence de Médecine Préventive (AMP), World Health Organization (WHO)
The MenAfriVac CTC experience in Benin: English version
Organisation Mondiale de la Santé (OMS), Agence de Médecine Préventive (AMP), PATH
Reportage sur l'utilisation du MenAfrivac en CTC
Diana Chang-Blanc, Ryan McWhorter, Ousmane Dia, Graça Matsinhe, Henok Benti, Philippe Jaillard, Jeff Sanderson
1. Global updates: Network design, system optimization and vaccine management best practice 2. Country innovations: Designing for the future and rethinking more fundamental design elements
BID Initiative
During this webinar, VaxTrac presents on common themes and implementation/scale-up challenges that were identified during the recent BLN Study Visit to Benin conducted between 11th and 16th July...
Home-based record (HBR) for Benin circa 2014
Home-based record (HBR) for Benin circa 2005
Caroline L Trotter et al.
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
Balcha G. Masresha et al.
In 2011, the 46 World Health Organization (WHO) African Region (AFR) member states established a goal of measles elimination* by 2020, by achieving 1) ≥95% coverage of their target populations with...
Elise Guillermet et al.
At the end of 2013, the Government of Benin and Agence de Médecine Préventive (AMP) launched a demonstration project in Comé Health Zone (HZ) to optimize the vaccine supply chain. A key part of...
Xiao Xian Huang et al.
Objective: At the end of 2013, a pilot experiment was carried out in Comé health zone (HZ) in an attempt to optimize the vaccine supply chain. Four commune vaccine storage facilities were replaced...
Wendy Prosser et al.
Introduction: Evidence suggests that immunization supply chains are becoming outdated and unable to deliver needed vaccines due to growing populations and new vaccine introductions. Redesigning a...
Bruce Y. Lee et al.
ackground While our previous work has shown that replacing existing vaccines with thermostable vaccines can relieve bottlenecks in vaccine supply chains and thus increase vaccine availability, the...
Mable Carole Tevi-Benissan et al.
Background Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Simona Zipursky et al.
In October 2012, the Meningococcal A conjugate vaccine MenAfriVac was granted a label variation to allow for its use in a controlled temperature chain (CTC), at temperatures of up to 40 °C for not...
World Health Organization (WHO)
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
Michael Favin et al.
In collaboration with WHO, IMMUNIZATIONbasics analyzed 126 documents from the global grey literature to identify reasons why eligible children had incomplete or no vaccinations. The main reasons for...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
Bruce Y. Lee et al.
While scientific studies can show the need for vaccine policy or operations changes, translating scientific findings to action is a complex process that needs to be executed appropriately for change...
Kathleen Tiffay et al.
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
M. Teresa Aguado et al.
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
Hamadou M DICKO
The primary objectives of this document are to provide a step-by-step approach of a successful acquisition/introduction of solar cold chain equipment for vaccines management, and to share the lessons...
Shawn T. Brown et al.
New vaccine introductions have put a strain on vaccine supply chains around the world. While increasing storage and transportation may be the most straightforward options, it is also important to...
Marcel Drach et al
The introduction of new vaccines with much higher prices than traditional vaccines results in increasing budgetary pressure on immunization programs in GAVI-eligible countries, increasing the need to...
International Vaccine Access Center (IVAC)
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV)* both globally...
Landry Kaucley and Pierre Levy
This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for...
World Health Organization (WHO), PATH
In November 2012, the first immunization campaign to use a controlled temperature chain (CTC) took place in northern Benin. This photo set by project Optimize contains images taken during the...